Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tonix Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Tonix Pharmaceuticals

Tonix Pharmaceuticals

Public

Tonix Pharmaceuticals: A New Jersey-based company repurposing drugs for CNS conditions, COVID-19 vaccine, and biodefense.

HQ
New York City, NY, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Tonix Pharmaceuticals, based in Chatham, New Jersey, is dedicated to repurposing drugs for central nervous system (CNS) conditions. The company is also developing a COVID-19 vaccine and engaging in biodefense projects. Their product portfolio includes TNX-SL and Tonmya™, both aimed at managing fibromyalgia. Tonix focuses on innovative solutions to address unmet medical needs in CNS disorders and infectious diseases.

Tonix Pharmaceuticals has achieved significant milestones, including highly statistically significant results in their second-phase clinical trial for TNX-SL and a positive pre-NDA CMC meeting with the FDA for Tonmya™. They have also secured a substantial contract from the U.S. Department of Defense for their broad-spectrum antiviral program. These accomplishments underscore their impact on advancing treatments for CNS conditions and infectious diseases.

Tonix Pharmaceuticals - Similar Companies

Aptinyx logo

Aptinyx

aptinyx.com

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Titan Pharmaceuticals logo

Titan Pharmaceuticals

titanpharm.com

Vanda Pharmaceuticals logo

Vanda Pharmaceuticals

Soligenix logo

Soligenix

Afraxis logo

Afraxis

NeuroCytonix logo

NeuroCytonix

neurocytonix.com

Tikvah Therapeutics logo

Tikvah Therapeutics

Neuropathix logo

Neuropathix

neuropathix.com

Pharmatrophix logo

Pharmatrophix

pharmatrophix.com

Emergent BioSolutions logo

Emergent BioSolutions

Neurolixis logo

Neurolixis

neurolixis.com

Eton Pharmaceuticals logo

Eton Pharmaceuticals

Tonix Pharmaceuticals - Quick Facts

Who are Tonix Pharmaceuticals' competitors?

Companies similar to Tonix Pharmaceuticals include Aptinyx, Supernus Pharmaceuticals, Neurana Pharmaceuticals and NeuroTherapeutics Pharma.

When was Tonix Pharmaceuticals founded?

Tonix Pharmaceuticals was founded in 2007.

Where is Tonix Pharmaceuticals' headquarters located?

Tonix Pharmaceuticals' headquarters is located in New York City, NY, US.

When was Tonix Pharmaceuticals' last funding round?

Tonix Pharmaceuticals' most recent funding round was for $30M (USD) in December 2023.

How much has Tonix Pharmaceuticals raised to-date?

As of Dec 20, 2023, Tonix Pharmaceuticals has raised a total of $308.3M (USD).

How many employees does Tonix Pharmaceuticals have?

Tonix Pharmaceuticals has 106 employees as of Feb 6, 2024.

Tonix Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Vaccine
Tags
  • Healthtech
Unique IDs
  • ein: 261434750
  • secCik: 0001430306
  • ticker: TNXP
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 1000Metal Mining
  • 2000Food And Kindred Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research